Jiangsu Bochuang Biotechnology
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- Undisclosed
Investors
- 2
About Jiangsu Bochuang Biotechnology
Established in 2022 and based in Suzhou, China, Jiangsu Bochuang Biotechnology Co,., trading as Jiangsu Bochuang Biotechnology, operates as a medical prosthetic product developer that focuses on the production and sales of collagen repair products and membrane repair products. The company was recognized as the National High-tech Enterprise. It cooperated with East China University of Science and Technology and Shanghai University. Changsheng Liu, the company's chief consultant, is an academician of the Chinese Academy of Sciences. In July 2023, it announced the successful trial production of its self-developed Type I newborn highly active collagen raw materials. The company provides collagen repair products and membrane repair products. Its products mainly include the artificial cornea, periosteum, dura mater, and nerve sheath tubes, such as E-Gide and E-Col. The artificial cornea is prepared using EDP technology, and the product's transmittance can reach over 95%. The company also develops an EDP technology platform for electrochemical deposition of biomolecules. The company will use the funds for the subsequent development and commercial conversion of the core products, Oral Bone Tissue Guiding Membrane (E-Gide) and Highly Transparent Collagen Prosthetic Cornea (E-Colcornea), as well as for the development of prosthetic heart valve. This investment aims to support Jiangsu Bochuang Biotechnology's research and innovation in the field of medical membrane materials and accelerate the market promotion of innovative products such as high-end artificial corneas, periosteums, and dura maters.
Who invested in Jiangsu Bochuang Biotechnology
2 investors across 2 rounds
See all investors in Jiangsu Bochuang Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiangsu Bochuang Biotechnology
Who invested in Jiangsu Bochuang Biotechnology?
Jiangsu Bochuang Biotechnology has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiangsu Bochuang Biotechnology raised?
Jiangsu Bochuang Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiangsu Bochuang Biotechnology last raise money?
Jiangsu Bochuang Biotechnology's most recent round on record is a Series A, in Mar 2026.
What does Jiangsu Bochuang Biotechnology do?
Established in 2022 and based in Suzhou, China, Jiangsu Bochuang Biotechnology Co,.
Where is Jiangsu Bochuang Biotechnology headquartered?
Jiangsu Bochuang Biotechnology is headquartered in Suzhou, China.
Which VCs invest in companies like Jiangsu Bochuang Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Jiangsu Bochuang Biotechnology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Jiangsu Bochuang Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.